NCT00003441 2018-10-25
Irofulven in Treating Patients With Metastatic Colorectal Cancer
M.D. Anderson Cancer Center
Phase 2 Completed
Clinical Trials
4 trialsNCT00003786 2014-03-07
Irofulven in Treating Patients With Metastatic or Recurrent Colorectal Cancer
University of Chicago
Phase 2 Withdrawn
NCT00062257 2013-05-15
Irofulven in Treating Patients With Recurrent or Metastatic Gastric Cancer
National Cancer Institute (NCI)
Phase 2 Completed
NCT00003760 2012-08-09
Irofulvene in Treating Patients With Stage III or Stage IV Pancreatic Cancer
The University of Texas Health Science Center at San Antonio
Phase 2 Completed